BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29563139)

  • 21. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
    Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
    Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression.
    Zhang X; Li B; de Jonge N; Björkholm M; Xu D
    Oncotarget; 2015 Mar; 6(7):4888-900. PubMed ID: 25682873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
    Goldkorn A; Blackburn EH
    Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.
    Vallarelli AF; Rachakonda PS; André J; Heidenreich B; Riffaud L; Bensussan A; Kumar R; Dumaz N
    Oncotarget; 2016 Aug; 7(33):53127-53136. PubMed ID: 27449293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines.
    Aschacher T; Wolf B; Enzmann F; Kienzl P; Messner B; Sampl S; Svoboda M; Mechtcheriakova D; Holzmann K; Bergmann M
    Oncogene; 2016 Jan; 35(1):94-104. PubMed ID: 25798839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
    Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
    Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
    Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
    Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between telomerase activity and proliferation in cutaneous melanoma.
    Zamolo G; Coklo M; Bosnar A; Batinac T
    Med Hypotheses; 2007; 68(1):125-7. PubMed ID: 16891062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.
    Llorca-Cardeñosa MJ; Peña-Chilet M; Mayor M; Gomez-Fernandez C; Casado B; Martin-Gonzalez M; Carretero G; Lluch A; Martinez-Cadenas C; Ibarrola-Villava M; Ribas G
    Eur J Cancer; 2014 Dec; 50(18):3168-77. PubMed ID: 25457634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel organometallic chloroquine derivative inhibits tumor growth.
    Hall EA; Ramsey JE; Peng Z; Hayrapetyan D; Shkepu V; O'Rourke B; Geiger W; Lam K; Verschraegen CF
    J Cell Biochem; 2018 Jul; 119(7):5921-5933. PubMed ID: 29575007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6.
    Yoshida A; Lee EK; Diehl JA
    Cancer Res; 2016 May; 76(10):2990-3002. PubMed ID: 26988987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
    Pathak S; Multani AS; McConkey DJ; Imam AS; Amoss MS
    Int J Oncol; 2000 Dec; 17(6):1219-24. PubMed ID: 11078808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.
    Niessner H; Schmitz J; Tabatabai G; Schmid AM; Calaminus C; Sinnberg T; Weide B; Eigentler TK; Garbe C; Schittek B; Quintanilla-Fend L; Bender B; Mai M; Praetorius C; Beissert S; Schackert G; Muders MH; Meinhardt M; Baretton GB; Dummer R; Flaherty K; Pichler BJ; Kulms D; Westphal D; Meier F
    Clin Cancer Res; 2016 Dec; 22(23):5818-5828. PubMed ID: 27307593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
    Jafri MA; Ansari SA; Alqahtani MH; Shay JW
    Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
    Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
    Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study.
    Kuranaga N; Shinomiya N; Mochizuki H
    BMC Cancer; 2001; 1():10. PubMed ID: 11518543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
    Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
    Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.